pubmed-article:12566909 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0013089 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:12566909 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
pubmed-article:12566909 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:12566909 | pubmed:dateCreated | 2003-2-4 | lld:pubmed |
pubmed-article:12566909 | pubmed:abstractText | To evaluate the efficacy and toxicity of concurrent administration of doxorubicin and docetaxel, without prophylactic use of granulocyte colony-stimulating factor, as first-line chemotherapy in patients with metastatic breast cancer (MBC). | lld:pubmed |
pubmed-article:12566909 | pubmed:language | eng | lld:pubmed |
pubmed-article:12566909 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12566909 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12566909 | pubmed:issn | 0030-2414 | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:NoguchiShinza... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:SonooHiroshiH | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:HorikoshiNobo... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:KatsumataNori... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:WatanabeToruT | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:SasakiYasutsu... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:DEVEFF | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:HirakiShunkic... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:TabeiToshioT | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:TakatsukaYuic... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:AiharaTomohik... | lld:pubmed |
pubmed-article:12566909 | pubmed:author | pubmed-author:ItohKuniakiK | lld:pubmed |
pubmed-article:12566909 | pubmed:copyrightInfo | Copyright 2003 S. Karger AG, Basel | lld:pubmed |
pubmed-article:12566909 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12566909 | pubmed:volume | 64 | lld:pubmed |
pubmed-article:12566909 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12566909 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12566909 | pubmed:pagination | 124-30 | lld:pubmed |
pubmed-article:12566909 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:meshHeading | pubmed-meshheading:12566909... | lld:pubmed |
pubmed-article:12566909 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12566909 | pubmed:articleTitle | Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer. | lld:pubmed |
pubmed-article:12566909 | pubmed:affiliation | Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan. aiharat@kanrou.net | lld:pubmed |
pubmed-article:12566909 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12566909 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12566909 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12566909 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:12566909 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12566909 | lld:pubmed |